These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18778936)

  • 1. Discovery and biological evaluation of benzo[a]carbazole-based small molecule agonists of the thrombopoietin (Tpo) receptor.
    Alper PB; Marsilje TH; Mutnick D; Lu W; Chatterjee A; Roberts MJ; He Y; Karanewsky DS; Chow D; Lao J; Gerken A; Tuntland T; Liu B; Chang J; Gordon P; Seidel HM; Tian SS
    Bioorg Med Chem Lett; 2008 Oct; 18(19):5255-8. PubMed ID: 18778936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of small molecule agonists of the thrombopoietin (Tpo) receptor derived from a benzo[a]carbazole hit scaffold.
    Marsilje TH; Alper PB; Lu W; Mutnick D; Michellys PY; He Y; Karanewsky DS; Chow D; Gerken A; Lao J; Kim MJ; Seidel HM; Tian SS
    Bioorg Med Chem Lett; 2008 Oct; 18(19):5259-62. PubMed ID: 18783949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular features crucial to the activity of pyrimidine benzamide-based thrombopoietin receptor agonists.
    Reiter LA; Jones CS; Brissette WH; McCurdy SP; Abramov YA; Bordner J; DiCapua FM; Munchhof MJ; Rescek DM; Samardjiev IJ; Withka JM
    Bioorg Med Chem Lett; 2008 May; 18(9):3000-6. PubMed ID: 18396041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of small molecule human C5a receptor antagonists.
    Sanganee HJ; Baxter A; Barber S; Brown AJ; Grice D; Hunt F; King S; Laughton D; Pairaudeau G; Thong B; Weaver R; Unitt J
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1143-7. PubMed ID: 19171482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling atypical small-molecule mimics of an important stem cell cytokine, thrombopoietin.
    Tarasova A; Winkler DA
    ChemMedChem; 2009 Dec; 4(12):2002-11. PubMed ID: 19810084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AKR-501 (YM477) a novel orally-active thrombopoietin receptor agonist.
    Fukushima-Shintani M; Suzuki K; Iwatsuki Y; Abe M; Sugasawa K; Hirayama F; Kawasaki T; Nakahata T
    Eur J Haematol; 2009 Apr; 82(4):247-54. PubMed ID: 19183407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo expansion of human hematopoietic stem cells by a small-molecule agonist of c-MPL.
    Nishino T; Miyaji K; Ishiwata N; Arai K; Yui M; Asai Y; Nakauchi H; Iwama A
    Exp Hematol; 2009 Nov; 37(11):1364-1377.e4. PubMed ID: 19744539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of small molecule agonists of the motilin receptor.
    Heightman TD; Conway E; Corbett DF; Macdonald GJ; Stemp G; Westaway SM; Celestini P; Gagliardi S; Riccaboni M; Ronzoni S; Vaidya K; Butler S; McKay F; Muir A; Powney B; Winborn K; Wise A; Jarvie EM; Sanger GJ
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6423-8. PubMed ID: 18980843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel C-3 N-urea, amide, and carbamate dihydroindazolo[5,4-a]pyrrolo[3,4-c]carbazole analogs as potent TIE-2 and VEGF-R2 dual inhibitors.
    Becknell NC; Zulli AL; Angeles TS; Yang S; Albom MS; Aimone LD; Robinson C; Chang H; Hudkins RL
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5368-72. PubMed ID: 16890434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships of xanthocillin derivatives as thrombopoietin receptor agonist.
    Yamaguchi T; Miyake Y; Miyamura A; Ishiwata N; Tatsuta K
    J Antibiot (Tokyo); 2006 Nov; 59(11):729-34. PubMed ID: 17256473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of oxoindolin-3-ylidene ethyl benzothiohydrazides as non-peptide TPO mimics.
    Tang PC; Lu HJ; Chen YQ; Wang SL; Zheng H; Wang L
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5062-4. PubMed ID: 20675136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New benzimidazoles as thrombopoietin receptor agonists.
    Safonov IG; Heerding DA; Keenan RM; Price AT; Erickson-Miller CL; Hopson CB; Levin JL; Lord KA; Tapley PM
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1212-6. PubMed ID: 16376078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The synergy between combinatorial chemistry and high-throughput screening.
    Diller DJ
    Curr Opin Drug Discov Devel; 2008 May; 11(3):346-55. PubMed ID: 18428088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of substituted indoline and carbazole by benzyne-mediated cyclization-functionalization.
    Noji T; Fujiwara H; Okano K; Tokuyama H
    Org Lett; 2013 Apr; 15(8):1946-9. PubMed ID: 23547831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc is not required for activity of TPO agonists acting at the c-Mpl receptor transmembrane domain.
    Andrade J; Cablewski T; Condie G; Haylock D; Meagher L; Riches A; Tarasova A; Werkmeister J; White J; Winkler D
    ACS Chem Biol; 2010 Aug; 5(8):741-5. PubMed ID: 20536264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xanthocillins as thrombopoietin mimetic small molecules.
    Sakai R; Nakamura T; Nishino T; Yamamoto M; Miyamura A; Miyamoto H; Ishiwata N; Komatsu N; Kamiya H; Tsuruzoe N
    Bioorg Med Chem; 2005 Dec; 13(23):6388-93. PubMed ID: 16115772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of small molecule interleukin-1 receptor antagonists based on a benzene template.
    Sarabu R; Cooper JP; Cook CM; Gillespie P; Perrotta AV; Olson GL
    Drug Des Discov; 1998 May; 15(3):191-8. PubMed ID: 9689501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationships and hepatic safety risks of thiazole agonists of the thrombopoietin receptor.
    Antipas AS; Blumberg LC; Brissette WH; Brown MF; Casavant JM; Doty JL; Driscoll J; Harris TM; Jones CS; McCurdy SP; McElroy E; Mitton-Fry M; Munchhof MJ; Reim DA; Reiter LA; Ripp SL; Shavnya A; Smeets MI; Trevena KA
    Bioorg Med Chem Lett; 2010 Jul; 20(14):4069-72. PubMed ID: 20558059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent and highly selective DP1 antagonists with 2,3,4,9-tetrahydro-1H-carbazole as pharmacophore.
    Li L; Beaulieu C; Carriere MC; Denis D; Greig G; Guay D; O'Neill G; Zamboni R; Wang Z
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7462-5. PubMed ID: 21036609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fe-catalyzed novel domino isomerization/cyclodehydration of substituted 2-[(indoline-3-ylidene)(methyl)]benzaldehyde derivatives: an efficient approach toward benzo[b]carbazole derivatives.
    Paul K; Bera K; Jalal S; Sarkar S; Jana U
    Org Lett; 2014 Apr; 16(8):2166-9. PubMed ID: 24742160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.